These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 23928368

  • 1. Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device.
    Segura AM, Radovancevic R, Demirozu ZT, Frazier OH, Buja LM.
    Cardiovasc Pathol; 2014; 23(1):17-20. PubMed ID: 23928368
    [Abstract] [Full Text] [Related]

  • 2. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT, Arat N, Kucukaksu DS.
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [Abstract] [Full Text] [Related]

  • 3. Variability in fibrosis in tissue samples obtained during diaphragmatic and apical LVAD implantation.
    Segura AM, Radovancevic R, Aguayo A, Frazier OH, Buja LM.
    Cardiovasc Pathol; 2014; 23(3):121-5. PubMed ID: 24484611
    [Abstract] [Full Text] [Related]

  • 4. Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure.
    Roberts WC, Vowels TJ, Ko JM, Capehart JE, Hall SA.
    Am J Cardiol; 2009 Jan 01; 103(1):110-4. PubMed ID: 19101239
    [Abstract] [Full Text] [Related]

  • 5. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A, Patil NP, Sabashnikov A, Mohite PN, Garcia Saez D, Bireta C, Wahlers T, Karck M, Kallenbach K, Ruhparwar A, Fatullayev J, Amrani M, De Robertis F, Bahrami T, Popov AF, Simon AR.
    Artif Organs; 2015 Apr 01; 39(4):336-42. PubMed ID: 25345547
    [Abstract] [Full Text] [Related]

  • 6. Myocardial size and fibrosis changes during left ventricular assist device support.
    Yamada Y, Saito S, Nishinaka T, Yamazaki K.
    ASAIO J; 2012 Apr 01; 58(4):402-6. PubMed ID: 22739784
    [Abstract] [Full Text] [Related]

  • 7. Pathological findings in cardiac apex removed during implantation of left ventricular assist devices (LVAD) are non-specific: 13-year-experience at a German Heart Center.
    Strecker T, Rösch J, Weyand M, Agaimy A.
    Int J Clin Exp Pathol; 2014 Apr 01; 7(9):5549-56. PubMed ID: 25337196
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
    Kühne M, Sakumura M, Reich SS, Sarrazin JF, Wells D, Chalfoun N, Crawford T, Boonyapisit W, Horwood L, Chugh A, Good E, Jongnarangsin K, Bogun F, Oral H, Morady F, Pagani F, Pelosi F.
    Am J Cardiol; 2010 Feb 01; 105(3):378-82. PubMed ID: 20102952
    [Abstract] [Full Text] [Related]

  • 9. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation.
    Atkins BZ, Hashmi ZA, Ganapathi AM, Harrison JK, Hughes GC, Rogers JG, Milano CA.
    J Thorac Cardiovasc Surg; 2013 Nov 01; 146(5):1247-52. PubMed ID: 23870154
    [Abstract] [Full Text] [Related]

  • 10. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP.
    Circ Arrhythm Electrophysiol; 2013 Aug 01; 6(4):668-74. PubMed ID: 23873139
    [Abstract] [Full Text] [Related]

  • 11. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
    Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yamauchi T, Kuratani T, Sawa Y.
    J Heart Lung Transplant; 2010 Jun 01; 29(6):672-9. PubMed ID: 20188595
    [Abstract] [Full Text] [Related]

  • 12. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ.
    Circulation; 1994 Nov 01; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [Abstract] [Full Text] [Related]

  • 13. Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis.
    Murray LK, González-Costello J, Jonas SN, Sims DB, Morrison KA, Colombo PC, Mancini DM, Restaino SW, Joye E, Horn E, Takayama H, Marboe CC, Naka Y, Jorde UP, Uriel N.
    Eur J Heart Fail; 2012 Mar 01; 14(3):312-8. PubMed ID: 22265922
    [Abstract] [Full Text] [Related]

  • 14. Similar left and right ventricular sarcomere structure after support with a left ventricular assist device suggests the utility of right ventricular biopsies to monitor left ventricular reverse remodeling.
    de Jonge N, Lahpor JR, van Wichen DF, Kirkels H, Gmelig-Meyling FH, van den Tweel JG, Doevendans PA, de Weger RA.
    Int J Cardiol; 2005 Feb 28; 98(3):465-70. PubMed ID: 15708181
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement.
    Soderlund KA, Chivukula RR, Russell SD, Conte JV, Mudd JO, Halushka MK.
    Cardiovasc Pathol; 2009 Feb 28; 18(4):217-22. PubMed ID: 18706833
    [Abstract] [Full Text] [Related]

  • 16. Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy.
    Boehmer JP, Starling RC, Cooper LT, Torre-Amione G, Wittstein I, Dec GW, Markham DW, Zucker MJ, Gorcsan J, McTiernan C, Kip K, McNamara DM, IMAC Investigators.
    J Card Fail; 2012 Oct 28; 18(10):755-61. PubMed ID: 23040110
    [Abstract] [Full Text] [Related]

  • 17. First clinical experience with the Incor left ventricular assist device.
    Schmid C, Tjan TD, Etz C, Schmidt C, Wenzelburger F, Wilhelm M, Rothenburger M, Drees G, Scheld HH.
    J Heart Lung Transplant; 2005 Sep 28; 24(9):1188-94. PubMed ID: 16143232
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices.
    Sacher F, Reichlin T, Zado ES, Field ME, Viles-Gonzalez JF, Peichl P, Ellenbogen KA, Maury P, Dukkipati SR, Picard F, Kautzner J, Barandon L, Koneru JN, Ritter P, Mahida S, Calderon J, Derval N, Denis A, Cochet H, Shepard RK, Corre J, Coffey JO, Garcia F, Hocini M, Tedrow U, Haissaguerre M, d'Avila A, Stevenson WG, Marchlinski FE, Jais P.
    Circ Arrhythm Electrophysiol; 2015 Jun 28; 8(3):592-7. PubMed ID: 25870335
    [Abstract] [Full Text] [Related]

  • 19. Morphologic changes in the aortic wall media after support with a continuous-flow left ventricular assist device.
    Segura AM, Gregoric I, Radovancevic R, Demirozu ZT, Buja LM, Frazier OH.
    J Heart Lung Transplant; 2013 Nov 28; 32(11):1096-100. PubMed ID: 23968812
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices.
    Grosman-Rimon L, Jacobs I, Tumiati LC, McDonald MA, Bar-Ziv SP, Fuks A, Kawajiri H, Lazarte J, Ghashghai A, Shogilev DJ, Cherney DZ, Rao V.
    Can J Cardiol; 2015 Mar 28; 31(3):348-56. PubMed ID: 25746024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.